By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Berlex Inc. (Acquired by Bayer AG in 2006) 

Press releases archived for reference only.
2600 Hilltop Drive
Richmond  California  94806  U.S.A.
Phone: 510-262-5000 Fax: n/a



Company News
Onmark Signs Exclusive Contracts with Pfizer Inc. (PFE) and Berlex for Oncology and Supportive Care Products 4/3/2007 10:53:23 AM
Berlex Inc. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment 4/2/2007 11:23:54 AM
Biotech Industry is Down, for Now -- Berlex Inc. (Jobs) Plans to Eliminate 210 East Bay Jobs 3/20/2007 2:27:30 AM
Favrille, Inc. (FVRL) Announces Agreement With Berlex Inc. Regarding Use Of FavId(R) In Combination With Leukine(R) (sargramostim) In B-Cell Non-Hodgkin's Lymphoma 2/14/2007 12:54:38 PM
Berlex Inc. And Premier, Inc. Sign New Agreement For Magnetic Resonance Contrast Media 1/4/2007 12:06:16 PM
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis 10/23/2006 11:27:50 AM
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD) 10/5/2006 9:25:05 AM
Berlex Inc. Issues Nationwide Recall Of A Single Lot Of Ultravist(R) Injection 370 mgI/mL, 125 mL In The U.S. 7/20/2006 6:37:20 PM
Berlex Inc. Release: New Autoinjection Device Designed To Work With Betaseron(R) Now Available For Patients With Multiple Sclerosis 7/11/2006 11:06:38 AM
Confirma, Inc. Products Now Available Through Berlex Inc.'s Accrual Program 5/22/2006 2:13:55 PM